XML 71 R59.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation - Summary of SARs Outstanding (Detail)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Sep. 30, 2017
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
SARs, beginning balance (shares) | shares 7,027
SARs, granted (shares) | shares 996
SARs, exercised (shares) | shares (1,445)
SARs, forfeited, canceled or expired (shares) | shares (112)
SARs, ending balance (shares) | shares 6,466
SARs, Vested and expected to vest at ending balance (shares) | shares 6,215
SARs, Exercisable at ending balance (shares) | shares 3,952
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
SARs, weighted average exercise price, beginning balance (USD per share) | $ / shares $ 103.83
SARs, weighted average exercise price, granted (USD per share) | $ / shares 170.69
SARs, weighted average exercise price, exercised (USD per share) | $ / shares 83.81
SARs, weighted average exercise price, forfeited, canceled or expired (USD per share) | $ / shares 142.04
SARs, weighted average exercise price, ending balance (USD per share) | $ / shares 117.94
SARs, weighted average exercise price, vested and expected to vest (USD per share) | $ / shares 116.54
SARs, weighted average exercise price, exercisable (USD per share) | $ / shares $ 96.00
SARs, weighted average remaining contractual term 6 years 2 months 26 days
SARs, weighted average remaining contractual term, vested and expected to vest 6 years 1 month 27 days
SARs, weighted average remaining contractual term, exercisable 4 years 11 months 22 days
SARs, aggregate intrinsic value | $ $ 504
SARs, aggregate intrinsic value, vested and expected to vest | $ 493
SARs, aggregate intrinsic value, exercisable | $ $ 395